Merck snags Chinese obesity drug in nearly $2 billion deal

Merck will gain the exclusive global license for Chinese drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors.

Em - News Moderator Em - News Moderator
Dec 19, 2024 - 06:00
Merck snags Chinese obesity drug in nearly $2 billion deal
Merck will gain the exclusive global license for Chinese drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors. Read More
Read More